MOH

Medicaid margins may have bottomed as state rate increases align with care costs, setting up a multiyear recovery cycle.

Is MOH a good stock to buy? We came across a bullish thesis on Molina Healthcare, Inc. on Valueinvestorsclub.com by banjo1055.

Molina Healthcare came into this earnings day on a quiet win streak, with the stock up over the past month, and then promptly dropped 3.5% to about US$209 after its Q3 2026 release.

Healthcare insurance company Molina Healthcare (NYSE:MOH) reported Q3 2026 results beating Wall Street’s revenue expectations, but sales fell by 3.4% year on year to $11.08 billion.

Molina Healthcare’s third quarter results reflected continued pressure from a challenging medical cost environment, with year-on-year declines in revenue and membership.

Molina Healthcare has delivered solid gains over the past year, yet its longer term share performance tells a more mixed story.

Molina Healthcare (MOH) just posted third quarter 2026 results that topped analyst revenue and earnings forecasts, reaffirmed full year guidance and pointed to early signs of improving Medicaid margins as medical costs begin to stabilize.

Molina Healthcare reported Q3 2026 revenue of US$11.08b and GAAP EPS of US$0.73, with adjusted EPS of US$0.89 and full year premium and earnings guidance reaffirmed.

Molina Healthcare (NYSE:MOH) reaffirmed its full-year 2026 adjusted earnings outlook while outlining preliminary 2027 earnings building blocks exceeding $9.50 per share, supported by anticipated rate increases, the maturation of new contracts and the planned…

Medicaid margins hit trough as Florida contract ramps and earnings harvest begins.

It’s the latest insurer to report momentum in the safety-net insurance program as states increase their payment rates and costs plateau. “The imbalance between rates and trend appears to have stabilized,” Molina’s CEO said.

Moby summary of Molina Healthcare, Inc.'s Q3 2026 earnings call